期刊文献+

靶向Galectin-1基因的siRNA真核表达载体构建及鉴定

Construction and identification of Galectin-1 targeting siRNA-expressing vector
下载PDF
导出
摘要 目的:构建Galectin-1特异性siRNA真核表达载体psilencircle-G1si,转染细胞株U14,下调Galec-tin-1的表达。方法:运用生物信息学技术候选siRNA序列,合成SECs转染U14细胞,以荧光定量PCR快速筛选有效序列;siRNA序列插入siRNA真核表达质粒psilencircle,构建psilencircle-G1si并转染U14细胞,实时荧光定量PCR、Western blot检测Galectin-1表达量。结果:psilencircle-G1si酶切、测序表明与设计一致,实时定量PCR及western blot表明psilecircle-G1si能调低U14细胞Galectin-1的表达。结论:成功构建Ga-lectin-1特异性siRNA真核表达载体psilencircle-Glsi。 Objective:To construct Galectin-1 targeting siRNA expressing vector and down regulate Galectin-1 expression in U14 cell line.Methods: The series sequence of Galectin-1 targeting siRNA were found by using bioinformatics tools.The siRNA expression cassettes(SECs) was generated by PCR,then U14 cells were transfected by Galectin-1 targeting SECs.The efficient SEC was chosen by comparison of Galectin-1 mRNA level using real time fluorescent quantitative PCR(FQ-PCR) and establish the psilecircle-G1si according to the sequence of efficient SEC.U14 cell line which transfected psilecircle-G1Si was analyzed by FQ-PCR and Western blotting.Results: psilecircle-G1Si was identified by restriction enzyme analysis and DNA sequence analysis.FQ-PCR and Western blotting results have shown Galectin-1 expression in U14 cells was down-regulated.Conclusion: The Galectin-1 siRNA plasmid(psilencircle-G1Si) has been successfully constructed.It might provide a foundation for further study on the strategy to avoid tumor cells killing T lymphocytes.
出处 《现代肿瘤医学》 CAS 2010年第10期1895-1898,共4页 Journal of Modern Oncology
基金 湖北省卫生厅指导性项目(编号:2007JX3C08) 三峡大学人才启动基金项目(编号:KJ2009B021)
关键词 GALECTIN-1 RNA干扰 表达载体 SECs Galectin-1 RNA interference expression vector SECs
  • 相关文献

参考文献7

  • 1Rabinovich GA.Galectin-1 as a potential cancer target[J].Br J Cancer,2005,92(7):1188-1192.
  • 2Natalia Rubinstein,Mariano Alvarez,Norberto W Zwirner,et al.Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection:A potential mechanism of tumor-immune privilege[J].Cancer Cell,2004,5:241-251.
  • 3张中华,侯永泰.siRNA制备技术的研究进展[J].生命科学,2004,16(4):231-235. 被引量:12
  • 4SM Yiu,Prudence WH Wong,TW Lam,et al.Filtering of ineffective siRNAs and improved siRNA design tool[J].Bioinformatics,2005,21(2):144-151.
  • 5Sakakibara Y,Popendorf K,Ogawa N,et al.Stem kernels for RNA sequence analyses[J].J Bioinform Comput Biol,2007,5(5):1103-1122.
  • 6Kenneth J Livak,Thomas D Schmittgen.Analysis of relative gene expression data using realtime quantitative PCR and the 2^-△△Ct method[J].Methods,2001,25:402-408.
  • 7陈复兴,李玺.肿瘤的细胞免疫治疗[J].国外医学(免疫学分册),2004,27(4):197-202. 被引量:25

二级参考文献39

  • 1Kikuchi T, Akasaki Y, Irie M, et al.Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells[J].Cancer Immunol Immunother,2001,50:337-344.
  • 2Roskrow BMA, Suzuki N, Gan YJ, et al.Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of patients with FBV-positive relapsed Hodgkin's disease[J].Blood, 1998,91 (8) :2925-2934.
  • 3Sykulev Y, Joo M, Vturina I, et al.Evidence that a single peptide-MHC complex on a target cell can licit A cytolytic T cell response[ J ].Immunity, 1996,4: 565-571.
  • 4Lum LG, Iefever AV,Treisman JS, et al.Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-coactivated T cellsphase I clinical trial[J] .J Immunother,2001,24(5) :408-419.
  • 5Ito F, Cart A, Svenssson H, et al.Antitumor reactivity of anti-CD3/antiCD28 bead-activated lymphoid cells: implications for cell therapy in a murine model [ J ].J Immunother, 2003,26 (3): 222-233.
  • 6lwashita Y, Tahara K, Goto S, et al.A phase I study of autologus dendritic cell-based immunotherapy for patients with unresectable primaryliver cancer[ J ].Cancer Immunol Immunother, 2003,52:155-161.
  • 7Yu JS, Wheeler CJ, Zeltyer PM, et al.Vaccination of malignant galioma patients with peptide-pulsed dendritic cells elicits system cytotoxity and Tcell infiltration[J].Cancer Res,2001,61(3) :842-847.
  • 8Holmers LM, Li JH, Sticca RP, et al.A padid, novel strategy to induce tumor cell-spccific cytotoxic T lymphocyte responses using instant dendritomas[J] .J Immunother,2001,24(2): 122-129.
  • 9Kugler A, Stuhleer G, Walden P, et al.Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrics[J].Nat Med,2000,6:332-336.
  • 10Marten A, Grten T, Ziske C, et al.Generation of activated and antigenspecific T cells with cytotoxic activity after co-culture with dendritic cells[J].Cancer Immunol Immunother,2002,51:25-32.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部